Asthma Predicts Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 6, 2015, Pages 1520-1525

  Tattersall, Matthew C ^a   Guo, Mengye ^b   Korcarz, Claudia E ^a   Gepner, Adam D ^a   Kaufman, Joel D ^b   Liu, Kiang J ^c   Barr, R Graham ^d   Donohue, Kathleen M ^e   McClelland, Robyn L ^a   Delaney, Joseph A ^b   Stein, James H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Mailman School of Public Health   (United States)

^e Howard Hughes Medical Institute   (United States)

Author keywords

asthma; atherosclerosis; epidemiology; risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; D DIMER; FIBRINOGEN; INTERLEUKIN 6; LEUKOTRIENE RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER;

ADULT; ANGINA PECTORIS; ARTICLE; ASTHMA; ATHEROSCLEROSIS; BLACK PERSON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROLLED STUDY; ETHNICITY; FEMALE; HEART INFARCTION; HISPANIC; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; AGED; BLOOD; COMPLICATION; ETHNOLOGY; INCIDENCE; PATHOPHYSIOLOGY; RISK FACTOR;

AGED; ASTHMA; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84933052748     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305452     Document Type: Article

References (30)

1. Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief. 2012:1-8. http://www.cdc. gov/nchs/data/databriefs/db94.pdf. Accessed April 24, 2015.
2. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695. doi: 10.1056/NEJMra043430.
4. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843. doi: 10.1056/NEJM200003233421202.
5. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303-1307.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979. doi: 10.1056/NEJM199704033361401.
7. Shrestha S, Irvin MR, Grunfeld C, Arnett DK. HIV, inflammation, and calcium in atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34:244-250. doi: 10.1161/ATVBAHA.113.302191.
8. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203. doi: 10.1371/journal.pmed.0050203.
9. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol. 2002;22:443-449.
10. Spanbroek R, Grabner R, Lotzer K, et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A. 2003;100:1238-1243. doi: 10.1073/pnas.242716099.
11. Iribarren C, Tolstykh IV, Eisner MD. Are patients with asthma at increased risk of coronary heart disease? Int J Epidemiol. 2004;33:743-748. doi: 10.1093/ije/dyh081.
12. Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax. 2005;60:633-638. doi: 10.1136/thx.2004.026484.
13. Torén K, Lindholm NB. Do patients with severe asthma run an increased risk from ischaemic heart disease? Int J Epidemiol. 1996;25:617-620.
14. Iribarren C, Tolstykh IV, Miller MK, Sobel E, Eisner MD. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. Am J Epidemiol. 2012;176:1014-1024. doi: 10.1093/aje/kws181.
15. Bellia V, Pedone C, Catalano F, Zito A, Daví E, Palange S, Forastiere F, Incalzi RA. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest. 2007;132:1175-1182. doi: 10.1378/chest.06-2824.
16. Lee HM, Truong ST, Wong ND. Association of adult-onset asthma with specific cardiovascular conditions. Respir Med. 2012;106:948-953. doi: 10.1016/j.rmed.2012.02.017.
17. Enright PL, Ward BJ, Tracy RP, Lasser EC. Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group. J Asthma. 1996;33:45-53.
18. Onufrak SJ, Abramson JL, Austin HD, Holguin F, McClellan WM, Vaccarino LV. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008;101:1247-1252. doi: 10.1016/j. amjcard.2007.12.024.
19. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol. 2002;89:381-385. doi: 10.1016/S1081-1206(10)62039-X.
20. Silverman E, Skinner J. Medicare upcoding and hospital ownership. J Health Econ. 2004;23:369-389. doi: 10.1016/j.jhealeco.2003.09.007.
21. Di Gennaro A, Haeggström JZ. The leukotrienes: immune-modulating lipid mediators of disease. Adv Immunol. 2012;116:51-92. doi: 10.1016/B978-0-12-394300-2.00002-8.
22. Qiu H, Gabrielsen A, Agardh HE, Wan M, Wetterholm A, Wong CH, Hedin U, Swedenborg J, Hansson GK, Samuelsson B, Paulsson-Berne G, Haeggström JZ. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A. 2006;103:8161-8166. doi: 10.1073/pnas.0602414103.
23. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax. 2004;59:892-896. doi: 10.1136/thx.2003.015768.
24. Fujita M, Ueki S, Ito W, Chiba T, Takeda M, Saito N, Kayaba H, Chihara J. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol. 2007;99:48-53. doi: 10.1016/S1081-1206(10)60620-5.
25. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, Jinnai M, Muro S, Hirai T, Ito Y, Nakamura T, Mio T, Chin K, Mishima M. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006;27:908-912. doi: 10.1183/09031936.06.00114405.
26. Karthikeyan R, Krishnamoorthy S, Maamidi S, Kaza AM, Balasubramanian N. Effect of inhaled corticosteroids on systemic inflammation in asthma. Perspect Clin Res. 2014;5:75-79. doi: 10.4103/2229-3485.128026.
27. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. NIH Publication Number 08-5846. J Allergy Clin Immunol. 2007:120:S94-138.
28. Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C. Cardiovascular safety of salmeterol in COPD. Chest. 2003;123:1817-1824.
29. Au DH, Lemaitre RN, Curtis JR, Smith NL, Psaty BM. The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists. Am J Respir Crit Care Med. 2000;161(3 Pt 1):827-830. doi: 10.1164/ajrccm.161.3.9904006..
30. Camargo CA Jr, Barr RG, Chen R, Speizer FE. Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest. 2008;134:546-551. doi: 10.1378/chest.07-3126.